» Authors » Michael Augenbraun

Michael Augenbraun

Explore the profile of Michael Augenbraun including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 69
Citations 1095
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
21.
Kuniholm M, OBrien T, Prokunina-Olsson L, Augenbraun M, Plankey M, Karim R, et al.
J Acquir Immune Defic Syndr . 2016 May; 72(2):162-70. PMID: 27183178
Background: Recent studies reported that the CD4/CD8 T-cell ratio is inversely associated with biomarkers traditionally used to measure immune activation and systemic inflammation in highly active antiretroviral therapy-treated HIV-infected (HIV+)...
22.
French A, Hotton A, Young M, Nowicki M, Augenbraun M, Anastos K, et al.
J Acquir Immune Defic Syndr . 2016 Feb; 72(3):274-80. PMID: 26918547
Background: Isolated hepatitis B core antibody (anti-HBc) is a common serologic finding in HIV-infected persons, but the clinical significance is uncertain. We studied HIV/hepatitis C virus (HCV)-infected women over time...
23.
Kerzerho J, McIlvaine E, Anthony P, Mack W, Wang C, Frederick T, et al.
J Acquir Immune Defic Syndr . 2016 Jan; 71(2):172-80. PMID: 26761519
Objectives: Hepatitis C virus (HCV) infection causes an alteration in T-cell maturation and activation in patients coinfected with human immunodeficiency virus (HIV). Because interleukin 7 (IL-7) is a major cytokine...
24.
Peters M, Bacchetti P, Boylan R, French A, Tien P, Plankey M, et al.
AIDS . 2015 Nov; 30(5):723-9. PMID: 26595542
Objective: Coinfection with hepatitis C virus (HCV) is a major cause of morbidity and mortality among individuals with HIV. Our objective was to assess the prognostic performance of noninvasive measures...
25.
Kuniholm M, Xie X, Anastos K, Kaplan R, Xue X, Kovacs A, et al.
J Acquir Immune Defic Syndr . 2014 Oct; 67(3):295-303. PMID: 25314250
Background: Hepatitis C virus (HCV) viremia is thought to have broad systemic effects on the cellular immune system that go beyond its impact on just those T cells that are...
26.
Kiefer E, Hoover D, Shi Q, Kuniholm M, Augenbraun M, Cohen M, et al.
J Acquir Immune Defic Syndr . 2014 Oct; 67(3):287-94. PMID: 25314249
: In HIV negatives, markers of hemostasis, including D-dimer, factor VIII, plasminogen activator inhibitor-1 antigen (PAI-1), and total protein S are associated with all-cause and cardiovascular disease mortality. In HIV...
27.
Kuniholm M, Parrinello C, Anastos K, Augenbraun M, Plankey M, Nowicki M, et al.
PLoS One . 2013 Apr; 8(4):e61973. PMID: 23613990
Background: Individuals with HIV infection exhibit high cytomegalovirus (CMV) IgG levels, but there are few data regarding the association of hepatitis C virus (HCV) with the immune response against CMV....
28.
Kohlhoff S, Crouch B, Roblin P, Fertel B, Pruitt D, Berg D, et al.
Disaster Med Public Health Prep . 2012 Dec; 6(4):378-84. PMID: 23241469
Objective: Nonpharmacologic interventions such as limiting nosocomial spread have been suggested for mitigation of respiratory epidemics at health care facilities. This observational study tested the efficacy of a mass screening,...
29.
Kiefer E, Shi Q, Hoover D, Kaplan R, Tracy R, Augenbraun M, et al.
J Acquir Immune Defic Syndr . 2012 Dec; 62(3):301-10. PMID: 23221984
Background: Coinfection with HIV and hepatitis C virus (HCV) is common. HIV infection and treatment are associated with hypercoagulability; thrombosis in HCV is underinvestigated. Proposed markers of hemostasis in HIV...
30.
Villacres M, Kono N, Mack W, Nowicki M, Anastos K, Augenbraun M, et al.
J Infect Dis . 2012 Jun; 206(5):780-9. PMID: 22693231
Background: Inflammation persists in treated human immunodeficiency virus (HIV) infection and may contribute to an increased risk for non-AIDS-related pathologies. We investigated the correlation of cytokine responses with changes in...